LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 40

Search options

  1. Article ; Online: A report of gonadal mosaicism in DHX30-related neurodevelopmental disorder.

    Cross, Laura A / McWalter, Kirsty / Keller-Ramey, Jennifer / Henderson, Lindsay B / Amudhavalli, Shivarajan M

    Clinical dysmorphology

    2020  Volume 29, Issue 3, Page(s) 161–164

    MeSH term(s) Gonads/embryology ; Humans ; Infant ; Infant, Newborn ; Male ; Mosaicism/embryology ; Mutation ; Mutation, Missense/genetics ; Neurodevelopmental Disorders/genetics ; RNA Helicases/genetics ; RNA Helicases/metabolism
    Chemical Substances DHX30 protein, human (EC 2.7.7.-) ; RNA Helicases (EC 3.6.4.13)
    Language English
    Publishing date 2020-01-15
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1121482-x
    ISSN 1473-5717 ; 0962-8827
    ISSN (online) 1473-5717
    ISSN 0962-8827
    DOI 10.1097/MCD.0000000000000316
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Intellectual disability syndrome associated with a homozygous founder variant in

    Birnbaum, Rivka / Ezer, Shlomit / Lotan, Nava Shaul / Eilat, Avital / Sternlicht, Keren / Benyamini, Lilach / Reish, Orit / Falik-Zaccai, Tzipora / Ben-Gad, Gali / Rod, Raya / Segel, Reeval / Kim, Katherine / Burton, Barabra / Keegan, Catherine E / Wagner, Mallory / Henderson, Lindsay B / Mor, Nofar / Barel, Ortal / Hirsch, Yoel /
    Meiner, Vardiella / Elpeleg, Orly / Harel, Tamar / Mor-Shakad, Hagar

    Journal of medical genetics

    2024  Volume 61, Issue 3, Page(s) 289–293

    Abstract: Background: Neurodevelopmental disorders (NDDs) impact both the development and functioning of the brain and exhibit clinical and genetic variability. RAP and RAB proteins, belonging to the RAS superfamily, are identified as established contributors to ... ...

    Abstract Background: Neurodevelopmental disorders (NDDs) impact both the development and functioning of the brain and exhibit clinical and genetic variability. RAP and RAB proteins, belonging to the RAS superfamily, are identified as established contributors to NDDs. However, the involvement of SGSM (small G protein signalling modulator), another member of the RAS family, in NDDs has not been previously documented.
    Methods: Proband-only or trio exome sequencing was performed on DNA samples obtained from affected individuals and available family members. The variant prioritisation process focused on identifying rare deleterious variants. International collaboration aided in the identification of additional affected individuals.
    Results: We identified 13 patients from 8 families of Ashkenazi Jewish origin who all carried the same homozygous frameshift variant in
    Conclusions: An Ashkenazi Jewish homozygous founder variant in
    MeSH term(s) Humans ; Intellectual Disability/genetics ; Jews/genetics ; Homozygote ; Syndrome ; Neurodevelopmental Disorders
    Language English
    Publishing date 2024-02-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmg-2023-109504
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Biallelic Loss-of-Function Variants in

    Hirsch, Yoel / Chung, Wendy K / Novoselov, Sergey / Weimer, Louis H / Rossor, Alexander / LeDuc, Charles A / McPartland, Amanda J / Cabrera, Ernesto / Ekstein, Josef / Scher, Sholem / Nelson, Rick F / Schiavo, Giampietro / Henderson, Lindsay B / Booth, Kevin T A

    International journal of molecular sciences

    2023  Volume 24, Issue 10

    Abstract: Hearing loss and peripheral neuropathy are two clinical entities that are genetically and phenotypically heterogeneous and sometimes co-occurring. Using exome sequencing and targeted segregation analysis, we investigated the genetic etiology of ... ...

    Abstract Hearing loss and peripheral neuropathy are two clinical entities that are genetically and phenotypically heterogeneous and sometimes co-occurring. Using exome sequencing and targeted segregation analysis, we investigated the genetic etiology of peripheral neuropathy and hearing loss in a large Ashkenazi Jewish family. Moreover, we assessed the production of the candidate protein via western blotting of lysates from fibroblasts from an affected individual and an unaffected control. Pathogenic variants in known disease genes associated with hearing loss and peripheral neuropathy were excluded. A homozygous frameshift variant in the
    MeSH term(s) Humans ; Adaptor Proteins, Signal Transducing/genetics ; Cytoskeletal Proteins/genetics ; Deafness/genetics ; Hearing Loss/genetics ; Pedigree ; Peripheral Nervous System Diseases/genetics ; Phenotype
    Chemical Substances Adaptor Proteins, Signal Transducing ; BICD1 protein, human ; Cytoskeletal Proteins
    Language English
    Publishing date 2023-05-17
    Publishing country Switzerland
    Document type Case Reports ; Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24108897
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: De Novo Missense Variants in SLC32A1 Cause a Developmental and Epileptic Encephalopathy Due to Impaired GABAergic Neurotransmission.

    Platzer, Konrad / Sticht, Heinrich / Bupp, Caleb / Ganapathi, Mythily / Pereira, Elaine M / Le Guyader, Gwenaël / Bilan, Frederic / Henderson, Lindsay B / Lemke, Johannes R / Taschenberger, Holger / Brose, Nils / Abou Jamra, Rami / Wojcik, Sonja M

    Annals of neurology

    2022  Volume 92, Issue 6, Page(s) 958–973

    Abstract: Objective: Rare inherited missense variants in SLC32A1, the gene that encodes the vesicular gamma-aminobutyric acid (GABA) transporter, have recently been shown to cause genetic epilepsy with febrile seizures plus. We aimed to clarify if de novo ... ...

    Abstract Objective: Rare inherited missense variants in SLC32A1, the gene that encodes the vesicular gamma-aminobutyric acid (GABA) transporter, have recently been shown to cause genetic epilepsy with febrile seizures plus. We aimed to clarify if de novo missense variants in SLC32A1 can also cause epilepsy with impaired neurodevelopment.
    Methods: Using exome sequencing, we identified four individuals with a developmental and epileptic encephalopathy and de novo missense variants in SLC32A1. To assess causality, we performed functional evaluation of the identified variants in a murine neuronal cell culture model.
    Results: The main phenotype comprises moderate-to-severe intellectual disability, infantile-onset epilepsy within the first 18 months of life, and a choreiform, dystonic, or dyskinetic movement disorder. In silico modeling and functional analyses reveal that three of these variants, which are located in helices that line the putative GABA transport pathway, result in reduced quantal size, consistent with impaired filling of synaptic vesicles with GABA. The fourth variant, located in the vesicular gamma-aminobutyric acid N-terminus, does not affect quantal size, but increases presynaptic release probability, leading to more severe synaptic depression during high-frequency stimulation. Thus, variants in vesicular gamma-aminobutyric acid can impair GABAergic neurotransmission through at least two mechanisms, by affecting synaptic vesicle filling and by altering synaptic short-term plasticity.
    Interpretation: This work establishes de novo missense variants in SLC32A1 as a novel cause of a developmental and epileptic encephalopathy. SUMMARY FOR SOCIAL MEDIA IF PUBLISHED: @platzer_k @lemke_johannes @RamiJamra @Nirgalito @GeneDx The SLC family 32 Member 1 (SLC32A1) is the only protein identified to date, that loads gamma-aminobutyric acid (GABA) and glycine into synaptic vesicles, and is therefore also known as the vesicular GABA transporter (VGAT) or vesicular inhibitory amino acid transporter (VIAAT). Rare inherited missense variants in SLC32A1, the gene that encodes VGAT/vesicular inhibitory amino acid transporter, have recently been shown to cause genetic epilepsy with febrile seizures plus. We aimed to clarify if de novo missense variants in SLC32A1 can also cause epilepsy with impaired neurodevelopment. We report on four individuals with de novo missense variants in SLC32A1 and a developmental and epileptic encephalopathy with infantile onset epilepsy. We establish causality of the variants via in silico modeling and their functional evaluation in a murine neuronal cell culture model. SLC32A1 variants represent a novel genetic etiology in neurodevelopmental disorders with epilepsy and a new GABA-related disease mechanism. ANN NEUROL 2022;92:958-973.
    MeSH term(s) Animals ; Mice ; Seizures, Febrile ; Epilepsy, Generalized/genetics ; Epilepsy/genetics ; Synaptic Transmission/genetics ; gamma-Aminobutyric Acid/metabolism ; Amino Acid Transport Systems/metabolism
    Chemical Substances gamma-Aminobutyric Acid (56-12-2) ; Amino Acid Transport Systems
    Language English
    Publishing date 2022-09-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.26485
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Biallelic variants in TUBGCP6 result in microcephaly and chorioretinopathy 1: Report of four cases and a literature review.

    Thomas-Wilson, Amanda / Schacht, John P / Chitayat, David / Blaser, Susan / Santos, Francis Jeshira Reynoso / Glaser, Kimberly / Caffo, Alesky / Wentzensen, Ingrid M / Henderson, Lindsay B / Zhang, Futao / Zhu, Ying / Di Corleto, Ellen / da Silva Costa, Fabricio / Vink, Rebecca / Alkhunaizi, Ebba / Russell, Laura / Buckley, Michael F / Roscioli, Tony / Pereira, Elaine Maria /
    Ganapathi, Mythily

    American journal of medical genetics. Part A

    2023  Volume 191, Issue 7, Page(s) 1935–1941

    Abstract: Autosomal recessive microcephaly and chorioretinopathy-1 (MCCRP1) is a rare Mendelian disorder resulting from biallelic loss of function variants in Tubulin-Gamma Complex Associated Protein 6 (TUBGCP6, MIM#610053). Clinical features of this disorder ... ...

    Abstract Autosomal recessive microcephaly and chorioretinopathy-1 (MCCRP1) is a rare Mendelian disorder resulting from biallelic loss of function variants in Tubulin-Gamma Complex Associated Protein 6 (TUBGCP6, MIM#610053). Clinical features of this disorder include microcephaly, cognitive impairment, dysmorphic features, and variable ophthalmological anomalies including chorioretinopathy. Microcephaly can be recognized prenatally and visual impairment becomes evident during the first year of life. The clinical presentation resembles the findings in some acquired conditions such as congenital toxoplasmosis and cytomegalovirus infections; thus, it is important to recognize and diagnose this syndrome in view of its impact on patient health management and familial reproductive plans. To date, only seven molecularly confirmed patients from five unrelated families have been reported. We report an additional four unrelated patients with TUBGCP6 variants including one prenatal diagnosis and review the clinical phenotypes and genotypes of all the known cases. This report expands the molecular and phenotypic spectrum of TUBGCP6 and includes additional prenatal findings associated with MCCRP1.
    MeSH term(s) Pregnancy ; Humans ; Female ; Microcephaly/diagnosis ; Microcephaly/genetics ; Microcephaly/complications ; Retinal Diseases ; Genotype ; Phenotype ; Microtubule-Associated Proteins/genetics
    Chemical Substances TUBGCP6 protein, human ; Microtubule-Associated Proteins
    Language English
    Publishing date 2023-04-09
    Publishing country United States
    Document type Review ; Case Reports ; Research Support, Non-U.S. Gov't
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.63203
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Haploinsufficiency of POU4F1 causes an ataxia syndrome with hypotonia and intention tremor.

    Webb, Bryn D / Evans, Anthony / Naidich, Thomas P / M Bird, Lynne / Parikh, Sumit / Fernandez Garcia, Meilin / Henderson, Lindsay B / Millan, Francisca / Si, Yue / Brennand, Kristen J / Hung, Peter / Rucker, Janet C / Wheeler, Patricia G / Schadt, Eric E

    Human mutation

    2021  Volume 42, Issue 6, Page(s) 685–693

    Abstract: De novo, heterozygous, loss-of-function variants were identified in Pou domain, class 4, transcription factor 1 (POU4F1) via whole-exome sequencing in four independent probands presenting with ataxia, intention tremor, and hypotonia. POU4F1 is expressed ... ...

    Abstract De novo, heterozygous, loss-of-function variants were identified in Pou domain, class 4, transcription factor 1 (POU4F1) via whole-exome sequencing in four independent probands presenting with ataxia, intention tremor, and hypotonia. POU4F1 is expressed in the developing nervous system, and mice homozygous for null alleles of Pou4f1 exhibit uncoordinated movements with newborns being unable to successfully right themselves to feed. Head magnetic resonance imaging of the four probands was reviewed and multiple abnormalities were noted, including significant cerebellar vermian atrophy and hypertrophic olivary degeneration in one proband. Transcriptional activation of the POU4F1 p.Gln306Arg protein was noted to be decreased when compared with wild type. These findings suggest that heterozygous, loss-of-function variants in POU4F1 are causative of a novel ataxia syndrome.
    MeSH term(s) Adult ; Ataxia/complications ; Ataxia/diagnosis ; Ataxia/genetics ; Ataxia/pathology ; Child ; Child, Preschool ; Female ; Haploinsufficiency ; Humans ; Magnetic Resonance Imaging ; Male ; Muscle Hypotonia/complications ; Muscle Hypotonia/diagnosis ; Muscle Hypotonia/genetics ; Mutation, Missense ; Retrospective Studies ; Syndrome ; Transcription Factor Brn-3A/genetics ; Tremor/complications ; Tremor/diagnosis ; Tremor/genetics ; United States ; Whole Exome Sequencing ; Young Adult
    Chemical Substances POU4F1 protein, human ; Transcription Factor Brn-3A
    Language English
    Publishing date 2021-04-15
    Publishing country United States
    Document type Case Reports ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1126646-6
    ISSN 1098-1004 ; 1059-7794
    ISSN (online) 1098-1004
    ISSN 1059-7794
    DOI 10.1002/humu.24201
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Heterozygous pathogenic variants involving

    Beyltjens, Tessi / Boudin, Eveline / Revencu, Nicole / Boeckx, Nele / Bertrand, Miriam / Schütz, Leon / Haack, Tobias B / Weber, Axel / Biliouri, Eleni / Vinkšel, Mateja / Zagožen, Anja / Peterlin, Borut / Pai, Shashidhar / Telegrafi, Aida / Henderson, Lindsay B / Ells, Courtney / Turner, Lesley / Wuyts, Wim / Van Hul, Wim /
    Hendrickx, Gretl / Mortier, Geert R

    Journal of medical genetics

    2022  Volume 60, Issue 5, Page(s) 498–504

    Abstract: Background: Cleidocranial dysplasia (CCD) is a rare skeletal dysplasia with significant clinical variability. Patients with CCD typically present with delayed closure of fontanels and cranial sutures, dental anomalies, clavicular hypoplasia or aplasia ... ...

    Abstract Background: Cleidocranial dysplasia (CCD) is a rare skeletal dysplasia with significant clinical variability. Patients with CCD typically present with delayed closure of fontanels and cranial sutures, dental anomalies, clavicular hypoplasia or aplasia and short stature. Runt-related transcription factor 2 (
    Methods: The cohort consists of eight subjects from five unrelated families partially identified through GeneMatcher. Exome or genome sequencing was applied and in two subjects the effect of the variant was investigated at RNA level.
    Results: In each subject a heterozygous pathogenic variant in
    Conclusion: We confirm the previously suggested locus heterogeneity for CCD by identifying five pathogenic variants in
    MeSH term(s) Humans ; Base Sequence ; Cleidocranial Dysplasia/genetics ; Cleidocranial Dysplasia/pathology ; Codon, Nonsense ; Core Binding Factor Alpha 1 Subunit/genetics ; Core Binding Factor beta Subunit/genetics ; Exons
    Chemical Substances CBFB protein, human ; Codon, Nonsense ; Core Binding Factor Alpha 1 Subunit ; Core Binding Factor beta Subunit
    Language English
    Publishing date 2022-10-14
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmg-2022-108739
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K

    Gripp, Karen W / Smithson, Sarah F / Scurr, Ingrid J / Baptista, Julia / Majumdar, Anirban / Pierre, Germaine / Williams, Maggie / Henderson, Lindsay B / Wentzensen, Ingrid M / McLaughlin, Heather / Leeuwen, Lisette / Simon, Marleen E H / van Binsbergen, Ellen / Dinulos, Mary Beth P / Kaplan, Julie D / McRae, Anne / Superti-Furga, Andrea / Good, Jean-Marc / Kutsche, Kerstin

    European journal of human genetics : EJHG

    2021  Volume 29, Issue 9, Page(s) 1384–1395

    Abstract: Decreased or increased activity of potassium channels caused by loss-of-function and gain-of-function (GOF) variants in the corresponding genes, respectively, underlies a broad spectrum of human disorders affecting the central nervous system, heart, ... ...

    Abstract Decreased or increased activity of potassium channels caused by loss-of-function and gain-of-function (GOF) variants in the corresponding genes, respectively, underlies a broad spectrum of human disorders affecting the central nervous system, heart, kidney, and other organs. While the association of epilepsy and intellectual disability (ID) with variants affecting function in genes encoding potassium channels is well known, GOF missense variants in K
    MeSH term(s) Abnormalities, Multiple/genetics ; Abnormalities, Multiple/pathology ; Adolescent ; Adult ; Channelopathies/genetics ; Channelopathies/pathology ; Child ; Craniofacial Abnormalities/genetics ; Craniofacial Abnormalities/pathology ; Ether-A-Go-Go Potassium Channels/genetics ; Female ; Fibromatosis, Gingival/genetics ; Fibromatosis, Gingival/pathology ; Gain of Function Mutation ; Hallux/abnormalities ; Hallux/pathology ; Hand Deformities, Congenital/genetics ; Hand Deformities, Congenital/pathology ; Humans ; Intellectual Disability/genetics ; Intellectual Disability/pathology ; Male ; Nails, Malformed/genetics ; Nails, Malformed/pathology ; Phenotype ; Potassium Channels/genetics ; Small-Conductance Calcium-Activated Potassium Channels/genetics ; Thumb/abnormalities ; Thumb/pathology
    Chemical Substances Ether-A-Go-Go Potassium Channels ; KCNH1 protein, human ; KCNK4 protein, human ; KCNN3 protein, human ; Potassium Channels ; Small-Conductance Calcium-Activated Potassium Channels
    Language English
    Publishing date 2021-02-16
    Publishing country England
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1141470-4
    ISSN 1476-5438 ; 1018-4813
    ISSN (online) 1476-5438
    ISSN 1018-4813
    DOI 10.1038/s41431-021-00818-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Expanding the molecular spectrum and the neurological phenotype related to CAMTA1 variants.

    Jacobs, Eva Z / Brown, Kathleen / Byler, Melissa C / D'haenens, Erika / Dheedene, Annelies / Henderson, Lindsay B / Humberson, Jennifer B / van Jaarsveld, Richard H / Kanani, Farah / Lebel, Robert Roger / Millan, Francisca / Oegema, Renske / Oostra, Ann / Parker, Michael J / Rhodes, Lindsay / Saenz, Margarita / Seaver, Laurie H / Si, Yue / Vanlander, Arnaud /
    Vergult, Sarah / Callewaert, Bert

    Clinical genetics

    2020  Volume 99, Issue 2, Page(s) 259–268

    Abstract: The CAMTA1-associated phenotype was initially defined in patients with intragenic deletions and duplications who showed nonprogressive congenital ataxia, with or without intellectual disability. Here, we describe 10 individuals with CAMTA1 variants: nine ...

    Abstract The CAMTA1-associated phenotype was initially defined in patients with intragenic deletions and duplications who showed nonprogressive congenital ataxia, with or without intellectual disability. Here, we describe 10 individuals with CAMTA1 variants: nine previously unreported (likely) pathogenic variants comprising one missense, four frameshift and four nonsense variants, and one missense variant of unknown significance. Six patients were diagnosed following whole exome sequencing and four individuals with exome-based targeted panel analysis. Most of them present with developmental delay, manifesting in speech and motor delay. Other frequent findings are hypotonia, cognitive impairment, cerebellar dysfunction, oculomotor abnormalities, and behavioral problems. Feeding problems occur more frequently than previously observed. In addition, we present a systematic review of 19 previously published individuals with causal variants, including copy number, truncating, and missense variants. We note a tendency of more severe cognitive impairment and recurrent dysmorphic features in individuals with a copy number variant. Pathogenic variants are predominantly observed in and near the N- and C- terminal functional domains. Clinical heterogeneity is observed, but 3'-terminal variants seem to associate with less pronounced cerebellar dysfunction.
    MeSH term(s) Adolescent ; Calcium-Binding Proteins/genetics ; Child ; Child, Preschool ; Cognition Disorders/genetics ; DNA Mutational Analysis ; Developmental Disabilities/genetics ; Female ; Humans ; Male ; Nervous System Diseases/genetics ; Phenotype ; Trans-Activators/genetics
    Chemical Substances CAMTA1 protein, human ; Calcium-Binding Proteins ; Trans-Activators
    Language English
    Publishing date 2020-11-23
    Publishing country Denmark
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Systematic Review
    ZDB-ID 221209-2
    ISSN 1399-0004 ; 0009-9163
    ISSN (online) 1399-0004
    ISSN 0009-9163
    DOI 10.1111/cge.13874
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The impact of chromosomal microarray on clinical management: a retrospective analysis.

    Henderson, Lindsay B / Applegate, Carolyn D / Wohler, Elizabeth / Sheridan, Molly B / Hoover-Fong, Julie / Batista, Denise A S

    Genetics in medicine : official journal of the American College of Medical Genetics

    2014  Volume 16, Issue 9, Page(s) 657–664

    Abstract: Purpose: Chromosomal microarray has been widely adopted as the first-tier clinical test for individuals with multiple congenital anomalies, developmental delay, intellectual disability, and autism spectrum disorders. Although chromosomal microarray has ... ...

    Abstract Purpose: Chromosomal microarray has been widely adopted as the first-tier clinical test for individuals with multiple congenital anomalies, developmental delay, intellectual disability, and autism spectrum disorders. Although chromosomal microarray has been extensively shown to provide a higher diagnostic yield than conventional cytogenetic methods, some health insurers refuse to provide coverage for this test, claiming that it is experimental and does not affect patients' clinical management.
    Methods: We retrospectively reviewed the electronic medical records of all patients who had abnormal chromosomal microarray findings reported by our laboratory over a 3-year period and quantified the management recommendations made in response to these results.
    Results: Abnormal chromosomal microarray findings were reported for 12.7% of patients (227/1,780). For patients with clinical follow-up notes available, these results had management implications for 54.5% of patients in the entire abnormal cohort (102/187) and for 42.1% of patients referred for isolated neurodevelopmental disorders (16/38). Recommendations included pharmacological treatment, cancer-related screening or exclusion of screening, contraindications, and referrals for further evaluation.
    Conclusion: These results empirically demonstrate the clinical utility of chromosomal microarray by providing evidence that management was directly affected for the majority of patients in our cohort with abnormal chromosomal microarray findings.
    MeSH term(s) Child ; Child, Preschool ; Chromosomes, Human ; Disease Management ; Early Detection of Cancer ; Female ; Follow-Up Studies ; Genetic Testing/methods ; Humans ; Infant ; Male ; Oligonucleotide Array Sequence Analysis ; Polymorphism, Single Nucleotide ; Referral and Consultation ; Retrospective Studies
    Language English
    Publishing date 2014-03-13
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1455352-1
    ISSN 1530-0366 ; 1098-3600
    ISSN (online) 1530-0366
    ISSN 1098-3600
    DOI 10.1038/gim.2014.18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top